Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.05 | -75% | ||
CN¥0.05 | -75% | ||
CN¥0.20 | -60% | ||
CN¥0.20 | -60% | ||
CN¥0.50 | 40.02% | ||
CN¥0.3571 | 99.94% | ||
CN¥0.1786 | 62.36% | ||
CN¥0.11 | -38.89% | ||
CN¥0.18 | 63.64% | ||
CN¥0.11 | 0% | ||
CN¥0.11 |
Zhejiang Starry Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 0.49%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €1.26
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Zhejiang Starry Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.05. For the next 12 months, Zhejiang Starry Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.05. This corresponds to a dividend yield of approximately 0.49%.
- The dividend yield of Zhejiang Starry Pharmaceutical Co Ltd Class A is currently 0.49%.
- Zhejiang Starry Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in September.
- The next dividend for Zhejiang Starry Pharmaceutical Co Ltd Class A is expected in September.
- Within the last 10 years, Zhejiang Starry Pharmaceutical Co Ltd Class A has paid dividends in 9 of them.
- Dividends of CN¥0.05 are expected for the next 12 months. This corresponds to a dividend yield of 0.49%.
- Zhejiang Starry Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Zhejiang Starry Pharmaceutical Co Ltd Class A was on 17 June 2022 in the ratio 1:1.
- To receive the last dividend of Zhejiang Starry Pharmaceutical Co Ltd Class A on 9 September 2024 in the amount of CN¥0.05 you had to have the stock in your portfolio before the ex-day on 9 September 2024.
- The last dividend was paid on 9 September 2024.
- In 2022, dividends of CN¥0.50 were paid by Zhejiang Starry Pharmaceutical Co Ltd Class A.
- Dividends from Zhejiang Starry Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Zhejiang Starry Pharmaceutical Co Ltd Class A is located in China.